GSK plc (GSK) Financials

GSK Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 81.3 billion 58.7 billion
March 31, 2026 109.4 billion 79.1 billion
Dec. 31, 2025 82.0 billion 60.5 billion
Sept. 30, 2025 111.0 billion 82.5 billion

GSK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 2.9 billion ?
March 31, 2026 921.4 million ?
Dec. 31, 2025 2.0 billion ?
Sept. 30, 2025 3.5 billion ?

GSK Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 579.3 million
March 31, 2026 2.4 billion
Dec. 31, 2025 843.5 million
Sept. 30, 2025 3.6 billion

GSK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 4.1 billion 18.4 billion -
March 31, 2026 6.0 billion 24.4 billion -
Dec. 31, 2025 4.6 billion 19.7 billion 1.1 billion
Sept. 30, 2025 6.0 billion 27.0 billion -

GSK Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 2.7 billion
March 31, 2026 2.7 billion
Dec. 31, 2025 2.7 billion
Sept. 30, 2025 2.8 billion

GSK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 435.8 million 4.6 billion 2.9 billion -
March 31, 2026 584.8 million 2.2 billion 2.8 billion -
Dec. 31, 2025 752.9 million 3.2 billion 3.5 billion -
Sept. 30, 2025 575.9 million 2.3 billion 3.0 billion -

GSK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 11.1 billion 3.0 billion
March 31, 2026 10.1 billion 2.5 billion
Dec. 31, 2025 11.6 billion 3.6 billion
Sept. 30, 2025 11.5 billion 3.0 billion

GSK

Price: $52.13

52 week price:
36.75
61.70

Dividend Yield: 3.48%

5-year range yield:
3.48%
10.26%

Forward Dividend Yield: 3.42%

Payout Ratio: 52.47%

Payout Ratio Range:
-1055.17%
938.88%

Dividend Per Share: 1.81 USD

Earnings Per Share: 3.15 USD

P/E Ratio: 16.41

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United Kingdom

Volume: 3.7 million

Ebitda: 2.0 billion

Market Capitalization: 103.2 billion

Average Dividend Frequency: 4

Years Paying Dividends: 43

DGR3: -6.18%

DGR5: -6.10%

DGR10: -4.85%

DGR20: 0.24%

Links: